CN113755474B - Carboxypeptidase, and coding gene and application thereof - Google Patents

Carboxypeptidase, and coding gene and application thereof Download PDF

Info

Publication number
CN113755474B
CN113755474B CN202110847356.9A CN202110847356A CN113755474B CN 113755474 B CN113755474 B CN 113755474B CN 202110847356 A CN202110847356 A CN 202110847356A CN 113755474 B CN113755474 B CN 113755474B
Authority
CN
China
Prior art keywords
carboxypeptidase
nucleic acid
lys
gly
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110847356.9A
Other languages
Chinese (zh)
Other versions
CN113755474A (en
Inventor
叶茂
邓毛程
李静
张远平
尚红岩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Industry Technical College
Original Assignee
Guangdong Industry Technical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Industry Technical College filed Critical Guangdong Industry Technical College
Priority to CN202110847356.9A priority Critical patent/CN113755474B/en
Publication of CN113755474A publication Critical patent/CN113755474A/en
Application granted granted Critical
Publication of CN113755474B publication Critical patent/CN113755474B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/485Exopeptidases (3.4.11-3.4.19)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a carboxypeptidase, and a coding gene and application thereof. The amino acid sequence of the carboxypeptidase is shown in SEQ ID NO. 1. The invention also provides a nucleotide sequence for coding the carboxypeptidase. The carboxypeptidase has the function of hydrolyzing almost all amino acid residues, has good application potential, and has important significance for enriching members of carboxypeptidase families and developing environmental resources of traditional condiments in China. Thus, it can be used to prepare small molecule oligopeptides, which can be prepared by: the carboxypeptidase provided by the invention is added into a hydrolysis reaction system containing a protein substrate, and the enzyme hydrolysis reaction is carried out for 2-8h at the temperature of 25-35 ℃ to obtain the corresponding small molecular oligopeptide.

Description

Carboxypeptidase, and coding gene and application thereof
Technical Field
The invention belongs to the field of genetic engineering and enzyme engineering, and particularly relates to carboxypeptidase and a coding gene and application thereof.
Background
Carboxypeptidases (CPs) refer to a class of exopeptidases that specifically catalyze the hydrolysis of the carboxy-terminal amino acid of polypeptide chains, and are industrial enzyme preparations with significant potential for use. Carboxypeptidases can be classified mainly into serine carboxypeptidases (EC.3.4.16), metallocarboxypeptidases (EC.3.4.17) and cysteine carboxypeptidases (EC.3.4.18), depending on the mechanism of action at the site of the enzyme activity. The application of carboxypeptidase mainly relates to a plurality of disciplines such as biology, chemistry, medicine and the like. For example, in the food and feed industries, the method can be used for preparing high F value oligopeptides, removing ochratoxin, debittering polypeptides, prolonging or specifically modifying bioactive polypeptides; in the field of biology, the method can be used for polypeptide synthesis and polypeptide amino acid sequence determination, and can also be used as a model enzyme to provide help for the research of other enzymes; in medical application, because the carboxypeptidase is widely involved in biochemical reaction of organisms, the purpose of diagnosing and treating diseases can be achieved by detecting the carboxypeptidase in vivo; in addition, the composition can be used for degrading in vivo harmful substances (methotrexate and the like) in medicine. In recent years, new functions and new applications of carboxypeptidase are continuously discovered and developed, so that the carboxypeptidase has higher research value and wider application prospect.
Metagenomics (Metagenomics) is an emerging scientific technology that has emerged in recent years with the rapid growth of microbiology and modern life sciences. The basic research idea is to directly extract the genomic DNA of all microorganisms in the environment, clone to a proper vector, construct a metagenomic library, collect the nucleic acid information of all microorganisms in the environment together, and obtain useful enzymes, antibiotics, active substances and the like from the library by using a sequence screening or functional screening mode. Many novel biocatalysts, such as esterases, cellulases, xylanases, beta-glucosidases and the like, have been successfully screened by metagenomic library technology, and many characteristic information about the novel enzymes are obtained on the basis of the biocatalysts.
So far, no relevant report exists at home and abroad in the research of searching a new carboxypeptidase gene from a metagenomic library.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a carboxypeptidase. The enzyme has low specificity to C-terminal amino acid residues, can hydrolyze almost all amino acid residues, and has important significance for enriching carboxypeptidase family members and developing a new way for hydrolyzing protein into flavor peptides.
Another object of the present invention is to provide a gene encoding the carboxypeptidase.
It is a further object of the present invention to provide the use of said carboxypeptidase.
The purpose of the invention is realized by the following technical scheme: a carboxypeptidase enzyme, having the amino acid sequence shown below:
MGSTVTEVKGMFSVRFIAIVTMLTLFLVLDLSAAAEKTGAALDYEANSGKILYQQNADEIIAIASMTKMMSQLEYLVHEAVDKGKIALDQKVKVSEGGYKTSQDIETSNVPENGGRFPNYTVKEYEPMAIFEGNGSATIARLAEGTAGKEVDFVLKMANDHAKEWGGSDICLKKYKFVNATGLTNKDLKGGPEGTTPEKNFEMSALDVAFVFAPQRLNPDGYPVQLDTAKIPGKKEFWRKNPFTSTGGNWMLPGIKQYDGLKWNKTGTSPEAEYKGFTGTVSEPEGETRNISVVIIKTYPSSNTARYYVDTKKHSYLIGGLILNNFEKKMYGTDSSVNFGQETISFDNARDKDVVVQTKQYISLPDQKGSKDVYKKMEFKSKGQEAPIKQGAKLGSMTISKDAEDPGFLSRGKSMKVTTSAIEFANEFTRSMREIGLLFFSGVWNAVDVKNNTVK。
a nucleotide sequence encoding the carboxypeptidase; preferably a nucleotide sequence without introns and with a complete open reading frame of 1365 bp; more preferably a sequence as shown below:
ATGGGTTCTACCGTTACCGAAGTTAAAGGTATGTTCTCTGTTCGTTTCATCGCTATCGTTACCATGCTGACCCTGTTCCTGGTTCTGGACCTGTCTGCTGCTGCTGAAAAAACCGGTGCTGCTCTGGACTACGAAGCTAACTCTGGTAAAATCCTGTACCAGCAGAACGCTGACGAAATCATCGCTATCGCTTCTATGACCAAAATGATGTCTCAGCTGGAATACCTGGTTCACGAAGCTGTTGACAAAGGTAAAATCGCTCTGGACCAGAAAGTTAAAGTTTCTGAAGGTGGTTACAAAACCTCTCAGGACATCGAAACCTCTAACGTTCCGGAAAACGGTGGTCGTTTCCCGAACTACACCGTTAAAGAATACGAACCGATGGCTATCTTCGAAGGTAACGGTTCTGCTACCATCGCTCGTCTGGCTGAAGGTACCGCTGGTAAAGAAGTTGACTTCGTTCTGAAAATGGCTAACGACCACGCTAAAGAATGGGGTGGTTCTGACATCTGCCTGAAAAAATACAAATTCGTTAACGCTACCGGTCTGACCAACAAAGACCTGAAAGGTGGTCCGGAAGGTACCACCCCGGAAAAAAACTTCGAAATGTCTGCTCTGGACGTTGCTTTCGTTTTCGCTCCGCAGCGTCTGAACCCGGACGGTTACCCGGTTCAGCTGGACACCGCTAAAATCCCGGGTAAAAAAGAATTCTGGCGTAAAAACCCGTTCACCTCTACCGGTGGTAACTGGATGCTGCCGGGTATCAAACAGTACGACGGTCTGAAATGGAACAAAACCGGTACCTCTCCGGAAGCTGAATACAAAGGTTTCACCGGTACCGTTTCTGAACCGGAAGGTGAAACCCGTAACATCTCTGTTGTTATCATCAAAACCTACCCGTCTTCTAACACCGCTCGTTACTACGTTGACACCAAAAAACACTCTTACCTGATCGGTGGTCTGATCCTGAACAACTTCGAAAAAAAAATGTACGGTACCGACTCTTCTGTTAACTTCGGTCAGGAAACCATCTCTTTCGACAACGCTCGTGACAAAGACGTTGTTGTTCAGACCAAACAGTACATCTCTCTGCCGGACCAGAAAGGTTCTAAAGACGTTTACAAAAAAATGGAATTCAAATCTAAAGGTCAGGAAGCTCCGATCAAACAGGGTGCTAAACTGGGTTCTATGACCATCTCTAAAGACGCTGAAGACCCGGGTTTCCTGTCTCGTGGTAAATCTATGAAAGTTACCACCTCTGCTATCGAATTCGCTAACGAATTCACCCGTTCTATGCGTGAAATCGGTCTGCTGTTCTTCTCTGGTGTTTGGAACGCTGTTGACGTTAAAAACAACACCGTTAAA。
the nucleotide sequence can be obtained by a chemical synthesis method, and can also be prepared by the following steps:
1. extracting an environmental sample of the traditional fermented food, extracting a total genome and purifying;
2. carrying out enzyme digestion treatment on the purified total genome;
3. connecting the enzyme digestion product to a cloning vector, constructing a metagenome library in the traditional fermented food environment in an electric shock transformation escherichia coli engineering bacterium, screening carboxypeptidase positive clones from the library by using a SIGEX (substrate induction-based gene expression method), and obtaining positive clones by high-throughput screening;
4. and (3) designing a primer through sequencing and Blast comparison, and carrying out chain enzyme polymerization reaction by using the designed primer by using a plasmid of a positive clone as a template so as to clone the nucleotide sequence.
The conventional fermented food in the step one comprises fermented bean curd, fermented soya beans, soybean paste, soy sauce and the like.
The enzyme described in step two is preferably Sau3AI.
The cloning vector in the three steps is preferably Puc118 BamHI/BAP.
The Escherichia coli engineering bacteria in the step three are preferably Escherichia coli DH5 alpha.
The SIGEX (substrate-induced gene expression based) approach described in step three was as follows: all the clones were cultured in a solid medium containing an inducer IPTG, expression of carboxypeptidase and fluorescent protein GFP was induced by IPTG, and positive clones expressing GFP with the strongest fluorescence (indirectly indicating the highest expression level of carboxypeptidase) were selected by a flow cytometer (FACS) according to the intensity of GFP fluorescence expression, in which clones expressing GFP must contain the carboxypeptidase operon and the corresponding carboxypeptidase gene.
The designed primers described in step four are as follows:
an upstream primer F1:5 'CGCGGATCCATGGTTCTACCGTTAC-3';
a downstream primer R1:5 'CGGAAGCTTTTTAACGGTGTTGTT-3'.
In addition, the invention also provides a preparation method of the carboxypeptidase, which can be obtained by a chemical synthesis method or by expression of the nucleotide sequence and comprises the following steps:
(1) Cloning the nucleotide sequence into an expression vector, and transferring into an expression cell to obtain a cell containing a recombinant vector;
(2) Culturing the cell containing the recombinant vector obtained in the step (1), inducing by IPTG, separating and purifying from the culture to obtain the carboxypeptidase. The carboxypeptidase has the ability to hydrolyze substantially all amino acid residues.
The expression vector in step (1) is preferably pET-32a (+).
The expression cell described in step (1) is preferably E.coli BL21 (DE 3).
The medium for the culture described in step (2) is preferably LB liquid medium containing 100. Mu.g/ml ampicillin.
The specific steps of the induction in the step (2) are as follows: when the cells containing the recombinant vector are grown to OD 600 When the concentration is not less than 0.7-0.9, IPTG is added to the final concentration of 0.5-1.5 mM, and the mixture is cultured for 20-25 h at the temperature of 20-30 ℃ and the speed of 150-250 r/min; when the cells containing the recombinant vector are grown to OD 600 When the concentration is 0.8, IPTG is added to a final concentration of 1mM, and the mixture is cultured at 25 ℃ and 200r/min for 22h.
The separation means in step (2) is preferably centrifugation.
In addition, the invention also provides the application of the carboxypeptidase in preparing small molecular oligopeptides, which preferably comprises the following steps: adding the carboxypeptidase into a hydrolysis reaction system containing a protein substrate, and carrying out enzymatic hydrolysis reaction for 2-8h at 25-60 ℃ to obtain the corresponding small molecular oligopeptide.
The protein substrate comprises soybean protein, corn protein, wheat protein, yeast protein and the like.
The temperature of the hydrolysis reaction system is preferably 35-55 ℃.
The pH value of the hydrolysis reaction system is 5-9; preferably 6 to 8.
The buffer solution in the hydrolysis reaction system is preferably an acetic acid buffer solution.
The mass concentration of the protein substrate in the hydrolysis reaction system is 1-10%; preferably 2%.
Compared with the prior art, the invention has the following advantages and effects:
(1) Compared with the prior art, the carboxypeptidase obtained from the metagenome library of the traditional condiment environment in China by applying the metagenome technology is found to have the function of hydrolyzing almost all amino acid residues, has good application potential, and has important significance for enriching members of carboxypeptidase families and developing the traditional condiment environment resources in China.
(2) According to the invention, through researching the optimal conditions of the enzyme in the process of hydrolyzing protein to generate small molecular oligopeptides, the carboxypeptidase disclosed by the invention is used for carrying out enzyme catalytic reaction for 2-8h at 25-35 ℃ in the process of hydrolyzing protein raw materials such as soybean protein, corn protein, wheat protein and yeast protein to generate small molecular oligopeptides, the mass concentration of the substrate is 1% -10%, the reaction conditions can be adopted to efficiently and quickly hydrolyze to generate small molecular oligopeptides, the molecular weight of the small molecular oligopeptides is less than or equal to 3000Da, and the carboxypeptidase has a good application value.
Drawings
FIG. 1 is an SDS-PAGE electrophoresis of carboxypeptidase purification provided by the invention; wherein, the Lane M is a protein Marker; lane 1 is crude recombinant protein enzyme solution (unpurified); lane 2 is the purified protein.
FIG. 2 is a graph showing the results of measurement of the optimum reaction temperature of the purified carboxypeptidase.
FIG. 3 is a graph showing the results of determination of optimum reaction pH of the purified carboxypeptidase.
Detailed Description
The present invention will be described in further detail with reference to examples and drawings, but the present invention is not limited thereto.
Example 1 acquisition of carboxypeptidase Gene and validation of proteolytic Generation of Small oligopeptide
1. Obtainment of carboxypeptidase Gene
A fermented food environment metagenome library is constructed from a fermented bean curd fermentation environment sample which is a traditional fermented food in China, and the method comprises the following specific steps: extracting and purifying a total genome; carrying out Sau3AI enzyme digestion treatment on the purified total genome; the enzyme digestion product is connected to a pUC118 BamHI/BAP vector, and an electric shock is used for transforming Escherichia coli DH5 alpha to construct a traditional fermented food environment metagenome library.
Culturing all the clones of the obtained genome library in a solid culture medium containing an inducer IPTG, inducing expression of carboxypeptidase and fluorescent protein GFP by using the IPTG, wherein all the clones expressing GFP gene necessarily contain the carboxypeptidase operon and the corresponding carboxypeptidase gene, and selecting a positive clone expressing GFP with strongest fluorescence (indirectly indicating that the expression amount of the carboxypeptidase is highest) by using a flow cytometer (FACS) according to the strength of the fluorescence expression of the GFP.
Extracting the plasmid of the positive clone, sending the plasmid to a sequencing company for sequencing to obtain a nucleic acid sequence of carboxypeptidase, wherein the nucleic acid sequence consists of 1365 bases and is shown as SEQ ID NO.2 and named as cp _215; the polypeptide coded by the nucleic acid contains 455 amino acids, the amino acid sequence of the polypeptide is shown in SEQ ID NO.1, and the polypeptide is named CP _215.
2. Cloning of Gene fragments
Designing an amplification primer according to the sequence of the nucleic acid cp _ 215: an upstream primer F1:5' -CGCGGATCCATGGGTTCTACCGTTAC-3' (the BamHI cleavage site sequence is underlined); a downstream primer R1:5' -CGGAAGCTTTTTAACGGTGTTGTT-3' (HindIII cleavage site sequence underlined).
Carrying out PCR amplification by taking plasmids of positive clones as a template and F1 and R1 as primers, wherein the reaction system is as follows: primeSTAR TM 0.2. Mu.l of HS DNA Ploymerase (2.5U/. Mu.l), 6. Mu.l of 5 Xbuffer, 2.4. Mu.l of dNTP Mix (2.5 mM), 0.5. Mu.l of template (100 ng/. Mu.l), 0.2. Mu.l of each of primers F1 and F2 (10 mM), and make up to 50. Mu.l of ultrapure water. And (3) PCR reaction conditions: pre-denaturation at 95 ℃ for 2min; denaturation at 98 ℃ for 10s, annealing at 70 ℃ for 15s, extension at 72 ℃ for 1.5min,30 cycles; extension at 72 ℃ for 10min,4 ℃.
And (3) purifying the PCR product by using a PCR product purification kit, performing double digestion for 16h by using BamHI and HindIII, connecting the PCR product with a pET-32a (+) (Invitrogen) expression vector treated in the same way, performing electric transformation to an expression host escherichia coli BL21 (DE 3), screening resistance, picking positive clones, extracting plasmid DNA, and performing sequencing verification to find that the nucleotide sequence of the plasmid is the same as the sequence in SEQ ID NO.2, so that a target gene fragment can be effectively obtained.
3. Obtaining of recombinant carboxypeptidase CP _215
Inoculating strains containing correct plasmid by sequencing verification into LB liquid medium containing 100 μ g/ml ampicillin, culturing at 30 deg.C and 250r/min for 14h, transferring to 100ml LB liquid medium containing 100 μ g/ml ampicillin at an inoculum size of 1 (v/v)%, and growing to OD 600 =0.8, adding isopropylthio-beta-D-galactoside to a final concentration of 1.0mM, culturing at 25 ℃ for 22h at 200r/min, centrifuging at 12000r/min for 5min, discarding the supernatant, suspending the thallus in 20ml 50mM Tri-HCl (pH7.5), crushing the thallus by an ultrasonic crusher (200 w, 5 seconds apart, 5 minutes all the way, ice bath), centrifuging at 4 ℃ at 13000r/min for 15min, and collecting the supernatant to obtain the crude enzyme solution of the recombinant carboxypeptidase.
The crude enzyme solution of recombinant carboxypeptidase was purified of recombinant protein using His-tag protein Purification kit Proband Purification system of Invitrogen company, and the specific procedures were carried out according to the company's product instructions. And (4) quickly freezing the purified recombinant protein by liquid nitrogen, and storing the recombinant protein in an ultralow temperature refrigerator. The concentration of the purified recombinant protein was 180. Mu.g/ml.
The results of the measurement of the crude enzyme solution and the purified protein by polyacrylamide gel electrophoresis are shown in FIG. 1. As can be seen, the carboxypeptidase of the invention can be successfully purified from a crude enzyme solution by using a His-tag protein Purification kit Proband Purification system.
4. Verification of function of generating small molecular oligopeptide by hydrolyzing protein
Adding 9ml of pH6.0 acid buffer solution (taking 54.6g of sodium acetate, adding 20ml of 1mol/L acetic acid solution for dissolving, and adding water for diluting to 500 ml) into 1ml or 10 mul of the crude enzyme solution of the recombinant carboxypeptidase to serve as a reaction medium, respectively testing different substrates (such as soybean protein, corn protein, wheat protein, yeast protein and the like) with the concentration of 2 (w/w)%, performing water bath reaction at 30 ℃ for 6h, and hydrolyzing to generate corresponding small-molecule oligopeptides, wherein the molecular weight of the small-molecule oligopeptides is less than or equal to 3000Da. The product was structurally characterized by GC-MS (gas chromatography-mass spectrometer).
Example 2 determination of optimum reaction temperature of recombinant carboxypeptidase CP-215
Using 100mM Tris-HCl buffer (pH7.0) at 1% (w/v) caseinAdding purified enzyme solution 100 μ L as substrate, keeping temperature at 20, 25, 30, 35, 40, 45, 50, 55 and 60 deg.C for 10min, rapidly adding 2ml of trichloroacetic acid with concentration of 0.4mol/L to stop reaction, standing at room temperature for 15min, centrifuging at 1000rpm for 10min, collecting supernatant 1ml, placing in test tube, adding 5ml of Na with concentration of 0.4mol/L 2 CO 3 Measuring absorbance A of the solution and 1ml of Folin phenol solution 680nm . As shown in FIG. 2, the recombinant carboxypeptidase CP _215 still has high catalytic activity at 35-55 ℃ and the optimal reaction temperature is 40 ℃.
Example 3 determination of pH value of optimum reaction of recombinant carboxypeptidase CP-215
Adding 10 mul of purified enzyme solution into 1% (w/v) casein as a substrate, respectively preserving the temperature at 40 ℃ for 10min under different pH values of pH4.0-7.0 (100 mM phosphate buffer solution) and pH7.0-9.0 (Tris-HCl buffer solution), rapidly adding 2ml of trichloroacetic acid with the concentration of 0.4mol/L to terminate the reaction, standing at room temperature for 15min, centrifuging at 1000rpm for 10min, taking 1ml of supernatant, placing the supernatant in a test tube, adding 5ml of 0.4mol/LNa 2 CO 3 Measuring absorbance A of the solution and 1ml of Folin phenol solution 680nm . As shown in FIG. 3, the optimum reaction pH of the recombinant carboxypeptidase CP _215 is 7.5, and the enzyme activity is still higher at pH 5.0-8.5.
The above embodiments are preferred embodiments of the present invention, but the present invention is not limited to the above embodiments, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Sequence listing
<110> Guangdong institute of light industry and technology
<120> carboxypeptidase, and coding gene and application thereof
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 455
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> carboxypeptidase
<400> 1
Met Gly Ser Thr Val Thr Glu Val Lys Gly Met Phe Ser Val Arg Phe
1 5 10 15
Ile Ala Ile Val Thr Met Leu Thr Leu Phe Leu Val Leu Asp Leu Ser
20 25 30
Ala Ala Ala Glu Lys Thr Gly Ala Ala Leu Asp Tyr Glu Ala Asn Ser
35 40 45
Gly Lys Ile Leu Tyr Gln Gln Asn Ala Asp Glu Ile Ile Ala Ile Ala
50 55 60
Ser Met Thr Lys Met Met Ser Gln Leu Glu Tyr Leu Val His Glu Ala
65 70 75 80
Val Asp Lys Gly Lys Ile Ala Leu Asp Gln Lys Val Lys Val Ser Glu
85 90 95
Gly Gly Tyr Lys Thr Ser Gln Asp Ile Glu Thr Ser Asn Val Pro Glu
100 105 110
Asn Gly Gly Arg Phe Pro Asn Tyr Thr Val Lys Glu Tyr Glu Pro Met
115 120 125
Ala Ile Phe Glu Gly Asn Gly Ser Ala Thr Ile Ala Arg Leu Ala Glu
130 135 140
Gly Thr Ala Gly Lys Glu Val Asp Phe Val Leu Lys Met Ala Asn Asp
145 150 155 160
His Ala Lys Glu Trp Gly Gly Ser Asp Ile Cys Leu Lys Lys Tyr Lys
165 170 175
Phe Val Asn Ala Thr Gly Leu Thr Asn Lys Asp Leu Lys Gly Gly Pro
180 185 190
Glu Gly Thr Thr Pro Glu Lys Asn Phe Glu Met Ser Ala Leu Asp Val
195 200 205
Ala Phe Val Phe Ala Pro Gln Arg Leu Asn Pro Asp Gly Tyr Pro Val
210 215 220
Gln Leu Asp Thr Ala Lys Ile Pro Gly Lys Lys Glu Phe Trp Arg Lys
225 230 235 240
Asn Pro Phe Thr Ser Thr Gly Gly Asn Trp Met Leu Pro Gly Ile Lys
245 250 255
Gln Tyr Asp Gly Leu Lys Trp Asn Lys Thr Gly Thr Ser Pro Glu Ala
260 265 270
Glu Tyr Lys Gly Phe Thr Gly Thr Val Ser Glu Pro Glu Gly Glu Thr
275 280 285
Arg Asn Ile Ser Val Val Ile Ile Lys Thr Tyr Pro Ser Ser Asn Thr
290 295 300
Ala Arg Tyr Tyr Val Asp Thr Lys Lys His Ser Tyr Leu Ile Gly Gly
305 310 315 320
Leu Ile Leu Asn Asn Phe Glu Lys Lys Met Tyr Gly Thr Asp Ser Ser
325 330 335
Val Asn Phe Gly Gln Glu Thr Ile Ser Phe Asp Asn Ala Arg Asp Lys
340 345 350
Asp Val Val Val Gln Thr Lys Gln Tyr Ile Ser Leu Pro Asp Gln Lys
355 360 365
Gly Ser Lys Asp Val Tyr Lys Lys Met Glu Phe Lys Ser Lys Gly Gln
370 375 380
Glu Ala Pro Ile Lys Gln Gly Ala Lys Leu Gly Ser Met Thr Ile Ser
385 390 395 400
Lys Asp Ala Glu Asp Pro Gly Phe Leu Ser Arg Gly Lys Ser Met Lys
405 410 415
Val Thr Thr Ser Ala Ile Glu Phe Ala Asn Glu Phe Thr Arg Ser Met
420 425 430
Arg Glu Ile Gly Leu Leu Phe Phe Ser Gly Val Trp Asn Ala Val Asp
435 440 445
Val Lys Asn Asn Thr Val Lys
450 455
<210> 2
<211> 1365
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> nucleotide sequence encoding carboxypeptidase
<400> 2
atgggttcta ccgttaccga agttaaaggt atgttctctg ttcgtttcat cgctatcgtt 60
accatgctga ccctgttcct ggttctggac ctgtctgctg ctgctgaaaa aaccggtgct 120
gctctggact acgaagctaa ctctggtaaa atcctgtacc agcagaacgc tgacgaaatc 180
atcgctatcg cttctatgac caaaatgatg tctcagctgg aatacctggt tcacgaagct 240
gttgacaaag gtaaaatcgc tctggaccag aaagttaaag tttctgaagg tggttacaaa 300
acctctcagg acatcgaaac ctctaacgtt ccggaaaacg gtggtcgttt cccgaactac 360
accgttaaag aatacgaacc gatggctatc ttcgaaggta acggttctgc taccatcgct 420
cgtctggctg aaggtaccgc tggtaaagaa gttgacttcg ttctgaaaat ggctaacgac 480
cacgctaaag aatggggtgg ttctgacatc tgcctgaaaa aatacaaatt cgttaacgct 540
accggtctga ccaacaaaga cctgaaaggt ggtccggaag gtaccacccc ggaaaaaaac 600
ttcgaaatgt ctgctctgga cgttgctttc gttttcgctc cgcagcgtct gaacccggac 660
ggttacccgg ttcagctgga caccgctaaa atcccgggta aaaaagaatt ctggcgtaaa 720
aacccgttca cctctaccgg tggtaactgg atgctgccgg gtatcaaaca gtacgacggt 780
ctgaaatgga acaaaaccgg tacctctccg gaagctgaat acaaaggttt caccggtacc 840
gtttctgaac cggaaggtga aacccgtaac atctctgttg ttatcatcaa aacctacccg 900
tcttctaaca ccgctcgtta ctacgttgac accaaaaaac actcttacct gatcggtggt 960
ctgatcctga acaacttcga aaaaaaaatg tacggtaccg actcttctgt taacttcggt 1020
caggaaacca tctctttcga caacgctcgt gacaaagacg ttgttgttca gaccaaacag 1080
tacatctctc tgccggacca gaaaggttct aaagacgttt acaaaaaaat ggaattcaaa 1140
tctaaaggtc aggaagctcc gatcaaacag ggtgctaaac tgggttctat gaccatctct 1200
aaagacgctg aagacccggg tttcctgtct cgtggtaaat ctatgaaagt taccacctct 1260
gctatcgaat tcgctaacga attcacccgt tctatgcgtg aaatcggtct gctgttcttc 1320
tctggtgttt ggaacgctgt tgacgttaaa aacaacaccg ttaaa 1365
<210> 3
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> upstream primer F1
<400> 3
cgcggatcca tgggttctac cgttac 26
<210> 4
<211> 24
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<220>
<223> downstream primer R1
<400> 4
cggaagcttt ttaacggtgt tgtt 24

Claims (9)

1. A carboxypeptidase enzyme, comprising: the amino acid sequence is shown in SEQ ID NO. 1.
2. A nucleic acid, wherein: is a nucleic acid encoding the carboxypeptidase of claim 1.
3. The nucleic acid of claim 2, wherein: the nucleic acid has no intron and has a complete open reading frame of 1365 bp.
4. The nucleic acid of claim 3, wherein: the sequence of the nucleic acid is shown as SEQ ID NO. 2.
5. The process for producing the carboxypeptidase of claim 1, comprising the steps of:
(1) Cloning the nucleic acid of any one of claims 2 to 4 into an expression vector, and transferring the nucleic acid into an expression cell to obtain a cell containing a recombinant vector;
(2) Culturing the cell containing the recombinant vector obtained in the step (1), inducing by IPTG, separating and purifying from the culture to obtain the carboxypeptidase.
6. The process for producing the carboxypeptidase of claim 5, wherein:
the expression vector in the step (1) is pET-32a (+);
the expression cell in the step (1) is escherichia coli BL21 (DE 3);
the culture medium in the step (2) is an LB liquid culture medium containing 100 mug/ml ampicillin.
7. The process for producing a carboxypeptidase of claim 5, wherein:
the specific steps of the induction in the step (2) are as follows: when the cells containing the recombinant vector are grown to OD 600 If the concentration is not less than 0.7-0.9, IPTG is added to the final concentration of 0.5-1.5 mM, and the mixture is cultured for 20-25 h at the temperature of 20-30 ℃ and the speed of 150-250 r/min.
8. Use of the carboxypeptidase of claim 1 to prepare a small molecule oligopeptide.
9. The use of a carboxypeptidase for preparing a small molecule oligopeptide according to claim 8, comprising the steps of: adding the carboxypeptidase of claim 1 into a hydrolysis reaction system containing a protein substrate, and performing enzymatic hydrolysis reaction at 25-35 ℃ for 2-8h to obtain a corresponding small molecular oligopeptide.
CN202110847356.9A 2021-07-27 2021-07-27 Carboxypeptidase, and coding gene and application thereof Active CN113755474B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110847356.9A CN113755474B (en) 2021-07-27 2021-07-27 Carboxypeptidase, and coding gene and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110847356.9A CN113755474B (en) 2021-07-27 2021-07-27 Carboxypeptidase, and coding gene and application thereof

Publications (2)

Publication Number Publication Date
CN113755474A CN113755474A (en) 2021-12-07
CN113755474B true CN113755474B (en) 2023-01-31

Family

ID=78787956

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110847356.9A Active CN113755474B (en) 2021-07-27 2021-07-27 Carboxypeptidase, and coding gene and application thereof

Country Status (1)

Country Link
CN (1) CN113755474B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102630923A (en) * 2012-04-19 2012-08-15 华南理工大学 Method for preparing soy sauce
JP5809129B2 (en) * 2012-12-26 2015-11-10 太子食品工業株式会社 Method for producing solid food processed using microorganisms
CN106591265B (en) * 2016-08-18 2019-08-13 武汉职业技术学院 A kind of penicillin binding protein and its application
CN107400666B (en) * 2017-09-11 2019-11-22 广东轻工职业技术学院 A kind of aminopeptidase and its encoding gene and application

Also Published As

Publication number Publication date
CN113755474A (en) 2021-12-07

Similar Documents

Publication Publication Date Title
CN110923221B (en) Alkaline protease high-temperature mutant from bacillus licheniformis
WO2022134236A1 (en) Alkaline protease mutant, gene thereof, engineering bacteria thereof, preparation method therefor and use thereof
CN110066777B (en) Endo-inulase and application thereof in production of fructo-oligosaccharide
CN113862233B (en) Method for improving acid stability of glucose oxidase, mutant Q241E/R499E, gene and application
CN107400666B (en) A kind of aminopeptidase and its encoding gene and application
CN111549018B (en) Protease mutant with improved thermal stability as well as coding gene and application thereof
CN110923222B (en) Novel alkaline protease acid mutant from bacillus licheniformis
CN111850008B (en) Signal peptides for promoting extracellular expression of proteins
CN114107266A (en) Protease mutant with improved heat resistance, and coding gene and application thereof
CN113430181A (en) Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof
CN113755474B (en) Carboxypeptidase, and coding gene and application thereof
CN109679941B (en) Cordyceps militaris fibrinolytic enzyme and preparation method and application thereof
CN114736880B (en) Mutant D497N of glucose oxidase GoxM10 with improved acid stability as well as derivative mutant and application thereof
CN113736766B (en) Collagen hydrolase and its coding gene, preparation method and use
CN112725315B (en) Application of chitosanase and mutant thereof in preparation of chitosan oligosaccharide
CN109777816B (en) Preparation method and application of chondroitin sulfate ABC enzyme protein
CN110819609A (en) Mutant lipase with improved thermal stability as well as preparation method and application thereof
CN115851787B (en) Leucine aminopeptidase producing gene, bacillus subtilis, construction method and application
CN110066814B (en) beta-D-glucosidase gene and encoding protein thereof
CN108504615B (en) Recombinant bacterium for producing acidic protease and application thereof
CN114621352B (en) Silicon fusion protein, preparation and application
CN107955814B (en) Promoter for improving protein expression efficiency
CN106635845B (en) Aspergillus niger strain capable of producing prolin protease at high yield
CN117004589A (en) Aminopeptidase mutant and application thereof
CN116790564A (en) Heat-resistant protease mutant and encoding gene and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant